Cargando…
One year later: The case of tocilizumab in COVID-19
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536517/ https://www.ncbi.nlm.nih.gov/pubmed/34711474 http://dx.doi.org/10.1016/j.ejim.2021.10.024 |
| _version_ | 1784588023771430912 |
|---|---|
| author | Campochiaro, Corrado Tomelleri, Alessandro Matucci-Cerinic, Marco Dagna, Lorenzo |
| author_facet | Campochiaro, Corrado Tomelleri, Alessandro Matucci-Cerinic, Marco Dagna, Lorenzo |
| author_sort | Campochiaro, Corrado |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8536517 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Federation of Internal Medicine. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85365172021-10-25 One year later: The case of tocilizumab in COVID-19 Campochiaro, Corrado Tomelleri, Alessandro Matucci-Cerinic, Marco Dagna, Lorenzo Eur J Intern Med Editorial European Federation of Internal Medicine. Published by Elsevier B.V. 2022-01 2021-10-23 /pmc/articles/PMC8536517/ /pubmed/34711474 http://dx.doi.org/10.1016/j.ejim.2021.10.024 Text en © 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editorial Campochiaro, Corrado Tomelleri, Alessandro Matucci-Cerinic, Marco Dagna, Lorenzo One year later: The case of tocilizumab in COVID-19 |
| title | One year later: The case of tocilizumab in COVID-19 |
| title_full | One year later: The case of tocilizumab in COVID-19 |
| title_fullStr | One year later: The case of tocilizumab in COVID-19 |
| title_full_unstemmed | One year later: The case of tocilizumab in COVID-19 |
| title_short | One year later: The case of tocilizumab in COVID-19 |
| title_sort | one year later: the case of tocilizumab in covid-19 |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536517/ https://www.ncbi.nlm.nih.gov/pubmed/34711474 http://dx.doi.org/10.1016/j.ejim.2021.10.024 |
| work_keys_str_mv | AT campochiarocorrado oneyearlaterthecaseoftocilizumabincovid19 AT tomellerialessandro oneyearlaterthecaseoftocilizumabincovid19 AT matuccicerinicmarco oneyearlaterthecaseoftocilizumabincovid19 AT dagnalorenzo oneyearlaterthecaseoftocilizumabincovid19 |